| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 7.521 | 30.216 | 13.175 | 11.555 | 10.539 | 4.582 |
| Total Income - EUR | - | - | - | - | 7.521 | 30.267 | 13.231 | 11.555 | 10.539 | 4.582 |
| Total Expenses - EUR | - | - | - | - | 6.719 | 21.732 | 12.928 | 15.697 | 13.385 | 7.323 |
| Gross Profit/Loss - EUR | - | - | - | - | 801 | 8.535 | 302 | -4.142 | -2.846 | -2.741 |
| Net Profit/Loss - EUR | - | - | - | - | 576 | 7.806 | 27 | -4.420 | -2.846 | -2.741 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dipersim Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 635 | 8.604 | 8.390 | 4.177 | 3.719 | 957 |
| Inventories | - | - | - | - | 0 | 0 | 889 | 892 | 890 | 885 |
| Receivables | - | - | - | - | 241 | 789 | 743 | 558 | 465 | 0 |
| Cash | - | - | - | - | 394 | 7.815 | 6.757 | 2.727 | 2.365 | 73 |
| Shareholders Funds | - | - | - | - | 618 | 8.453 | 8.292 | 3.898 | 1.041 | -1.706 |
| Social Capital | - | - | - | - | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | - | 17 | 151 | 98 | 279 | 2.679 | 2.664 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Dipersim Bio S.r.l.